The approximate 50% of prostate cancers has fusion mutations, and TMPRSS2 ERG is the most common fusion gene. It is closely related to the aggressiveness and prognosis of prostate cancer. The EGR positive patients tend to have a higher stage of prostate cancer, a higher rate of recurrence, and a higher rate of pelvic lymph node metastasis.
Esophagus tissue stained with ERG
CODE |
Solution de travail |
CONCENTRATED SOLUTION |
||||
CER-0071 |
SPÉCIFICATION |
1 ml |
3 ml |
6 ml |
0.1ml |
0.2ml |
Cloner: C12A8
Source: Lapin
Localisation: Nucleus
Pretreatment: Thermal remediation
Tissu applicable: Paraffin section